These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8761884)
21. Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species. Wellfelt K; Sköld AC; Wallin A; Danielsson BR Reprod Toxicol; 1999; 13(2):93-101. PubMed ID: 10213516 [TBL] [Abstract][Full Text] [Related]
22. Reduction in fluid secretion by rat testis by drugs that block potassium channels. Setchell BP; Plöen L; Ritzen EM J Reprod Fertil; 1998 Jan; 112(1):87-94. PubMed ID: 9538333 [TBL] [Abstract][Full Text] [Related]
23. The effect of drugs with ion channel-blocking activity on the early embryonic rat heart. Abela D; Ritchie H; Ababneh D; Gavin C; Nilsson MF; Khan MK; Carlsson K; Webster WS Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):429-40. PubMed ID: 20973055 [TBL] [Abstract][Full Text] [Related]
24. Effects of macrolide antibiotics on rat embryonic heart function in vitro. Nilsson MF; Webster WS Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):189-98. PubMed ID: 24753334 [TBL] [Abstract][Full Text] [Related]
25. Antipsychotic drugs cause bradycardia in GD 13 rat embryos in vitro. Gunnström M; Ababneh D; Webster WS; Oakes D; Ritchie H Reprod Toxicol; 2012 Nov; 34(3):443-50. PubMed ID: 22750488 [TBL] [Abstract][Full Text] [Related]
26. Teratogenicity of the I(Kr)-blocker cisapride: relation to embryonic cardiac arrhythmia. Sköld AC; Danielsson C; Linder B; Danielsson BR Reprod Toxicol; 2002; 16(4):333-42. PubMed ID: 12220593 [TBL] [Abstract][Full Text] [Related]
27. Long-term programming effects on blood pressure following gestational exposure to the I Prestipino L; Polson JW; Brolin E; Ritchie HE Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29504284 [TBL] [Abstract][Full Text] [Related]
28. A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media. Ritchie HE; Svensson CH; Nilsson MF; Webster WS J Pharmacol Toxicol Methods; 2014; 70(3):276-82. PubMed ID: 25091319 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats. Danielsson B; Sköld AC; Azarbayjani F; Ohman I; Webster W Toxicol Appl Pharmacol; 2000 Mar; 163(2):164-75. PubMed ID: 10698674 [TBL] [Abstract][Full Text] [Related]
30. Role of mutation and pharmacologic block of human KCNH2 in vasculogenesis and fetal mortality: partial rescue by transforming growth factor-β. Teng G; Zhao X; Lees-Miller JP; Belke D; Shi C; Chen Y; O'Brien ER; Fedak PW; Bracey N; Cross JC; Duff HJ Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):420-8. PubMed ID: 25648353 [TBL] [Abstract][Full Text] [Related]
31. Effects of isotretinoin (13-cis-retinoic acid) on the development of mouse limbs in vivo and in vitro. Kwasigroch TE; Bullen M Teratology; 1991 Dec; 44(6):605-16. PubMed ID: 1805431 [TBL] [Abstract][Full Text] [Related]
32. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
33. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data. Walker DK; Alabaster CT; Congrave GS; Hargreaves MB; Hyland R; Jones BC; Reed LJ; Smith DA Drug Metab Dispos; 1996 Apr; 24(4):447-55. PubMed ID: 8801060 [TBL] [Abstract][Full Text] [Related]
34. Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography. Okada Y; Ogawa S; Sadanaga T; Mitamura H J Am Coll Cardiol; 1996 Jan; 27(1):84-9. PubMed ID: 8522715 [TBL] [Abstract][Full Text] [Related]
35. Dofetilide, a novel class III antiarrhythmic agent. Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316 [TBL] [Abstract][Full Text] [Related]
36. [3H]dofetilide binding: biological models that manifest solely the high or the low affinity binding site. Fiset C; Feng ZP; Wang L; Sheldon RS; Duff HJ J Mol Cell Cardiol; 1996 May; 28(5):1085-96. PubMed ID: 8762045 [TBL] [Abstract][Full Text] [Related]
37. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Webster WS; Brown-Woodman PD Teratology; 1990 Jun; 41(6):689-97. PubMed ID: 2353316 [TBL] [Abstract][Full Text] [Related]
38. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. Fiset C; Drolet B; Hamelin BA; Turgeon J J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319 [TBL] [Abstract][Full Text] [Related]
39. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs? Azarbayjani F; Danielsson BR Teratology; 1998 Mar; 57(3):117-26. PubMed ID: 9587965 [TBL] [Abstract][Full Text] [Related]
40. Comparative effects of sodium channel blockers in short term rat whole embryo culture. Nilsson MF; Sköld AC; Ericson AC; Annas A; Villar RP; Cebers G; Hellmold H; Gustafson AL; Webster WS Toxicol Appl Pharmacol; 2013 Oct; 272(2):306-12. PubMed ID: 23845595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]